Clinical Trial Update: A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated Fuzeon (enfuvirtide) in combination with an integrase inhibitor-based regimen and optimized background in treatment-experienced HIV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fuzeon (enfuvirtide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 4 | Status: TERMINATED | Results posted: 2011-06-29